BioCentury | Nov 25, 2020
Regulation

With Oxlumo’s approval, Alnylam aims to speed access with new value-based pricing framework

...principle with three commercial payers —the Express Scripts...
BioCentury | Aug 8, 2020
Product Development

First oral SMA therapy will be delivered to patients’ homes, well placed for virtual launch

...drug to patients’ homes within two weeks via the Accredo Health Group Inc. unit of Express Scripts...
...SMN2 - Survival of motor neuron 2 centromeric Sandi Wong, Assistant Editor risdiplam (RG7916, RO7034067) Genentech Inc. PTC Therapeutics Inc. Express Scripts...
BioCentury | Jan 29, 2020
Politics & Policy

Industry leaders applaud CVS zero co-pay diabetes drug access

...other indications include hypertension, Crohn’s disease, arthritis and multiple sclerosis (MS), said Hastings. In April, Express Scripts...
...caps out-of-pocket costs, including co-pays and deductibles, for insulin products at $25 per month (see “Express Scripts...
...1; GLP-1R (GLP1R) - Glucagon-like peptide-1; DPP-4 (CD26) - Dipeptidyl peptidase-4 Lauren Martz, Senior Editor CVS Health Corp. Express Scripts...
BioCentury | Jan 18, 2020
Product Development

Hard, measurable outcomes drive Express Scripts digital formulary

...of how Express Scripts is moving forward.” The demonstration of hard clinical benefits and ROI for Express Scripts...
...uptake and demonstrate the commercial potential of digital health technology. On Dec. 12, 2019, the Express Scripts...
...because they have select features that are specific to the indications. Table: Express Scripts digital formulary Express Scripts...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...a pharmacy consultant at Cambridge Advisory Group, and prior positions include VP of finance at Express Scripts...
BioCentury | Sep 24, 2019
Company News

Cigna eases burden of high cost gene therapies; plan doesn’t account for lack of benefit

...for consumers and eliminate cost-sharing for the beneficiary. According to Jennifer Luddy, spokesperson for Cigna's Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Rethinking first principles

...Are Figuring Out What It’s Worth” ). In the U.S., pharmacy benefit managers such as Express Scripts...
...Health Corp. (NYSE:CVS), Woonsocket, R.I. Elektra Labs, Boston, Mass. Evidation Health Inc., San Mateo, Calif. Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Digital tech meets the patient: first movers are bringing digital to biopharma

...Ligi told BioCentury. He added that Sandoz is working with PBMs such as Cigna Corp.’s Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Digital health: payers are figuring out what it’s worth

...will come next year when U.S. pharmacy benefit managers CVS Health Corp. and Cigna Corp.’s Express Scripts...
...digital health can be tough to run and may not be universally feasible.” Mark Bini, Express Scripts...
...Services Group and Boston Medical Center, according to a May press release. Fleshing it out Express Scripts...
BioCentury | May 24, 2019
Company News

AveXis says label makes Zolgensma gene therapy ‘treatment of choice’ for newly diagnosed SMA

...distributed in the U.S. exclusively through CuraScript SD. Accredo and CuraScript SD are units of Express Scripts...
Items per page:
1 - 10 of 252
BioCentury | Nov 25, 2020
Regulation

With Oxlumo’s approval, Alnylam aims to speed access with new value-based pricing framework

...principle with three commercial payers —the Express Scripts...
BioCentury | Aug 8, 2020
Product Development

First oral SMA therapy will be delivered to patients’ homes, well placed for virtual launch

...drug to patients’ homes within two weeks via the Accredo Health Group Inc. unit of Express Scripts...
...SMN2 - Survival of motor neuron 2 centromeric Sandi Wong, Assistant Editor risdiplam (RG7916, RO7034067) Genentech Inc. PTC Therapeutics Inc. Express Scripts...
BioCentury | Jan 29, 2020
Politics & Policy

Industry leaders applaud CVS zero co-pay diabetes drug access

...other indications include hypertension, Crohn’s disease, arthritis and multiple sclerosis (MS), said Hastings. In April, Express Scripts...
...caps out-of-pocket costs, including co-pays and deductibles, for insulin products at $25 per month (see “Express Scripts...
...1; GLP-1R (GLP1R) - Glucagon-like peptide-1; DPP-4 (CD26) - Dipeptidyl peptidase-4 Lauren Martz, Senior Editor CVS Health Corp. Express Scripts...
BioCentury | Jan 18, 2020
Product Development

Hard, measurable outcomes drive Express Scripts digital formulary

...of how Express Scripts is moving forward.” The demonstration of hard clinical benefits and ROI for Express Scripts...
...uptake and demonstrate the commercial potential of digital health technology. On Dec. 12, 2019, the Express Scripts...
...because they have select features that are specific to the indications. Table: Express Scripts digital formulary Express Scripts...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...a pharmacy consultant at Cambridge Advisory Group, and prior positions include VP of finance at Express Scripts...
BioCentury | Sep 24, 2019
Company News

Cigna eases burden of high cost gene therapies; plan doesn’t account for lack of benefit

...for consumers and eliminate cost-sharing for the beneficiary. According to Jennifer Luddy, spokesperson for Cigna's Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Rethinking first principles

...Are Figuring Out What It’s Worth” ). In the U.S., pharmacy benefit managers such as Express Scripts...
...Health Corp. (NYSE:CVS), Woonsocket, R.I. Elektra Labs, Boston, Mass. Evidation Health Inc., San Mateo, Calif. Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Digital tech meets the patient: first movers are bringing digital to biopharma

...Ligi told BioCentury. He added that Sandoz is working with PBMs such as Cigna Corp.’s Express Scripts...
BioCentury | Aug 31, 2019
Product Development

Digital health: payers are figuring out what it’s worth

...will come next year when U.S. pharmacy benefit managers CVS Health Corp. and Cigna Corp.’s Express Scripts...
...digital health can be tough to run and may not be universally feasible.” Mark Bini, Express Scripts...
...Services Group and Boston Medical Center, according to a May press release. Fleshing it out Express Scripts...
BioCentury | May 24, 2019
Company News

AveXis says label makes Zolgensma gene therapy ‘treatment of choice’ for newly diagnosed SMA

...distributed in the U.S. exclusively through CuraScript SD. Accredo and CuraScript SD are units of Express Scripts...
Items per page:
1 - 10 of 252